$GLYC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in GLYCOMIMETICS INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in GLYCOMIMETICS INC. Get notifications about new insider transactions in GLYCOMIMETICS INC for free.

Page:   1 2 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 27 2021GLYCGLYCOMIMETICS INCAndrews Patricia SDirectorOption ExerciseA2.5510,50026,77510,500
May 27 2021GLYCGLYCOMIMETICS INCAndrews Patricia SDirectorGrantA0.005,25005,2500 to 5.3 K
May 27 2021GLYCGLYCOMIMETICS INCGoldberg Mark AlanDirectorOption ExerciseA2.5510,50026,77510,500
May 27 2021GLYCGLYCOMIMETICS INCGoldberg Mark AlanDirectorGrantA0.005,25005,2500 to 5.3 K
Jan 22 2021GLYCGLYCOMIMETICS INCGirard ArmandSVP, Chief Business ...Option ExerciseA3.8150,000190,50050,000
Jan 22 2021GLYCGLYCOMIMETICS INCGirard ArmandSVP, Chief Business ...GrantA0.0025,000025,0000 to 25 K
Jan 22 2021GLYCGLYCOMIMETICS INCHahn Brian M.SVP Finance, CFOOption ExerciseA3.8169,000262,89069,000
Jan 22 2021GLYCGLYCOMIMETICS INCHahn Brian M.SVP Finance, CFOGrantA0.0034,500039,7605.3 K to 39.8 K (+655.89 %)
Jan 22 2021GLYCGLYCOMIMETICS INCThackray Helen M.SVP Clinical Develo ...Option ExerciseA3.8169,000262,89069,000
Jan 22 2021GLYCGLYCOMIMETICS INCThackray Helen M.SVP Clinical Develo ...GrantA0.0034,5000183,115148.6 K to 183.1 K (+23.21 %)
Jan 22 2021GLYCGLYCOMIMETICS INCMagnani John L.SVP of Research, CS ...Option ExerciseA3.8169,000262,89069,000
Jan 22 2021GLYCGLYCOMIMETICS INCMagnani John L.SVP of Research, CS ...GrantA0.0034,5000324,260289.8 K to 324.3 K (+11.91 %)
Jan 22 2021GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOOption ExerciseA3.81192,500733,425192,500
Jan 22 2021GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOGrantA0.0096,2500452,314356.1 K to 452.3 K (+27.03 %)
Dec 30 2020GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOOption ExerciseM1.12130,821146,5200
Dec 30 2020GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOSellS3.9184,176329,128356,064440.2 K to 356.1 K (-19.12 %)
Dec 30 2020GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOBuyM1.12130,821146,520440,240309.4 K to 440.2 K (+42.28 %)
Dec 17 2020GLYCGLYCOMIMETICS INCHahn Brian M.SVP Finance, CFOOption ExerciseM1.125,2605,8910
Dec 17 2020GLYCGLYCOMIMETICS INCHahn Brian M.SVP Finance, CFOBuyM1.125,2605,8915,2600 to 5.3 K
Nov 03 2020GLYCGLYCOMIMETICS INCBVF PARTNERS L P/IL10% OwnerBuyP2.7515,47242,548544,363528.9 K to 544.4 K (+2.93 %)
Nov 03 2020GLYCGLYCOMIMETICS INCBVF PARTNERS L P/IL10% OwnerBuyP2.75250,755689,5763,206,1953 M to 3.2 M (+8.48 %)
Nov 03 2020GLYCGLYCOMIMETICS INCBVF PARTNERS L P/IL10% OwnerBuyP2.75666,3851,832,5594,306,3203.6 M to 4.3 M (+18.31 %)
Nov 03 2020GLYCGLYCOMIMETICS INCBVF PARTNERS L P/IL10% OwnerBuyP2.7515,47242,548544,363528.9 K to 544.4 K (+2.93 %)
Nov 03 2020GLYCGLYCOMIMETICS INCBVF PARTNERS L P/IL10% OwnerBuyP2.75250,755689,5763,206,1953 M to 3.2 M (+8.48 %)
Nov 03 2020GLYCGLYCOMIMETICS INCBVF PARTNERS L P/IL10% OwnerBuyP2.75666,3851,832,5594,306,3203.6 M to 4.3 M (+18.31 %)
May 27 2020GLYCGLYCOMIMETICS INCJUNIUS DANIEL MDirectorOption ExerciseA3.0021,00063,00021,000
May 27 2020GLYCGLYCOMIMETICS INCPEARSON TIMOTHY RDirectorOption ExerciseA3.0021,00063,00021,000
May 27 2020GLYCGLYCOMIMETICS INCKoenig ScottDirectorOption ExerciseA3.0021,00063,00021,000
May 27 2020GLYCGLYCOMIMETICS INCGoldberg Mark AlanDirectorOption ExerciseA3.0021,00063,00021,000
May 27 2020GLYCGLYCOMIMETICS INCAndrews Patricia SDirectorOption ExerciseA3.0021,00063,00021,000
Mar 10 2020GLYCGLYCOMIMETICS INCJUNIUS DANIEL MDirectorBuyP3.4020,00068,00038,00018 K to 38 K (+111.11 %)
Jan 24 2020GLYCGLYCOMIMETICS INCGirard ArmandSVP, Chief Business ...Option ExerciseA4.72100,000472,000100,000
Jan 24 2020GLYCGLYCOMIMETICS INCMagnani John L.SVP of Research, CS ...Option ExerciseA4.72120,000566,400120,000
Jan 24 2020GLYCGLYCOMIMETICS INCHahn Brian M.SVP Finance, CFOOption ExerciseA4.72120,000566,400120,000
Jan 24 2020GLYCGLYCOMIMETICS INCThackray Helen M.SVP Clinical Develo ...Option ExerciseA4.72120,000566,400120,000
Jan 24 2020GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOOption ExerciseA4.72349,0001,647,280349,000
Jan 06 2020GLYCGLYCOMIMETICS INCMagnani John L.SVP of Research, CS ...Option ExerciseM1.12106,983119,8210
Jan 06 2020GLYCGLYCOMIMETICS INCMagnani John L.SVP of Research, CS ...BuyM1.12106,983119,821289,760182.8 K to 289.8 K (+58.53 %)
Dec 23 2019GLYCGLYCOMIMETICS INCMagnani John L.SVP of Research, CS ...Option ExerciseM1.12106,984119,822106,983
Dec 23 2019GLYCGLYCOMIMETICS INCMagnani John L.SVP of Research, CS ...BuyM1.12106,984119,822182,77775.8 K to 182.8 K (+141.15 %)
Sep 09 2019GLYCGLYCOMIMETICS INCBVF PARTNERS L P/IL10% OwnerBuyP3.18124,956397,610528,891403.9 K to 528.9 K (+30.93 %)
Sep 09 2019GLYCGLYCOMIMETICS INCBVF PARTNERS L P/IL10% OwnerBuyP3.18689,8342,195,0522,955,4402.3 M to 3 M (+30.45 %)
Sep 09 2019GLYCGLYCOMIMETICS INCBVF PARTNERS L P/IL10% OwnerBuyP3.18853,9562,717,2883,639,9352.8 M to 3.6 M (+30.65 %)
Aug 15 2019GLYCGLYCOMIMETICS INCJUNIUS DANIEL MDirectorBuyP3.1810,00031,80018,0008 K to 18 K (+125.00 %)
Aug 15 2019GLYCGLYCOMIMETICS INCJUNIUS DANIEL MDirectorBuyP3.1810,00031,80018,0008 K to 18 K (+125.00 %)
Aug 07 2019GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOOption ExerciseM1.12166,759186,770130,821
Aug 07 2019GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOBuyM1.12166,759186,770307,144140.4 K to 307.1 K (+118.79 %)
May 21 2019GLYCGLYCOMIMETICS INCAndrews Patricia SDirectorOption ExerciseA12.3921,000260,19021,000
May 21 2019GLYCGLYCOMIMETICS INCJUNIUS DANIEL MDirectorOption ExerciseA12.3921,000260,19021,000
May 21 2019GLYCGLYCOMIMETICS INCKoenig ScottDirectorOption ExerciseA12.3921,000260,19021,000
May 21 2019GLYCGLYCOMIMETICS INCPEARSON TIMOTHY RDirectorOption ExerciseA12.3921,000260,19021,000
May 21 2019GLYCGLYCOMIMETICS INCGoldberg Mark AlanDirectorOption ExerciseA12.3921,000260,19021,000
May 21 2019GLYCGLYCOMIMETICS INCJackson Scott ThomasDirectorOption ExerciseA12.3921,000260,19021,000
Jan 22 2019GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOOption ExerciseA10.59265,0002,806,350265,000
Jan 22 2019GLYCGLYCOMIMETICS INCMagnani John L.SVP of Research, CS ...Option ExerciseA10.59100,0001,059,000100,000
Jan 22 2019GLYCGLYCOMIMETICS INCThackray Helen M.SVP Clinical Develo ...Option ExerciseA10.59100,0001,059,000100,000
Jan 22 2019GLYCGLYCOMIMETICS INCHahn Brian M.SVP Finance, CFOOption ExerciseA10.5990,000953,10090,000
Nov 28 2018GLYCGLYCOMIMETICS INCJackson Scott ThomasDirectorOption ExerciseA11.5222,000253,44022,000
Oct 18 2018GLYCGLYCOMIMETICS INCMagnani John L.SVP of Research, CS ...SellS14.023,52749,44975,79379.3 K to 75.8 K (-4.45 %)
Oct 18 2018GLYCGLYCOMIMETICS INCMagnani John L.SVP of Research, CS ...SellS14.007,273101,82279,32086.6 K to 79.3 K (-8.40 %)
Oct 18 2018GLYCGLYCOMIMETICS INCMagnani John L.SVP of Research, CS ...SellS14.0114,200198,94286,593100.8 K to 86.6 K (-14.09 %)
Jun 12 2018GLYCGLYCOMIMETICS INCHahn Brian M.CFOOption ExerciseM1.125,2605,8915,260
Jun 12 2018GLYCGLYCOMIMETICS INCHahn Brian M.CFOSellS18.0419,345348,984019.3 K to 0 (-100.00 %)
Jun 12 2018GLYCGLYCOMIMETICS INCHahn Brian M.CFOBuyM1.125,2605,89119,34514.1 K to 19.3 K (+37.34 %)
May 24 2018GLYCGLYCOMIMETICS INCMagnani John L.SVP of Research, CS ...Option ExerciseM0.335961970
May 24 2018GLYCGLYCOMIMETICS INCMagnani John L.SVP of Research, CS ...Option ExerciseM0.338952950
May 24 2018GLYCGLYCOMIMETICS INCMagnani John L.SVP of Research, CS ...BuyM0.331,491492100,79399.3 K to 100.8 K (+1.50 %)
May 21 2018GLYCGLYCOMIMETICS INCBARRETT M JAMESDirectorOption ExerciseA18.4111,000202,51011,000
May 21 2018GLYCGLYCOMIMETICS INCGoldberg Mark AlanDirectorOption ExerciseA18.4111,000202,51011,000
May 21 2018GLYCGLYCOMIMETICS INCKoenig ScottDirectorOption ExerciseA18.4111,000202,51011,000
May 11 2018GLYCGLYCOMIMETICS INCSANDELL SCOTT D10% OwnerOption ExerciseX0.33298,40698,4740
May 11 2018GLYCGLYCOMIMETICS INCSANDELL SCOTT D10% OwnerOption ExerciseX0.33216,04671,2950
May 11 2018GLYCGLYCOMIMETICS INCSANDELL SCOTT D10% OwnerSellS17.815,53398,5434,995,6645 M to 5 M (-0.11 %)
May 11 2018GLYCGLYCOMIMETICS INCSANDELL SCOTT D10% OwnerBuyX0.33298,40698,4745,001,1974.7 M to 5 M (+6.35 %)
May 11 2018GLYCGLYCOMIMETICS INCSANDELL SCOTT D10% OwnerSellS17.814,00671,3474,702,7914.7 M to 4.7 M (-0.09 %)
May 11 2018GLYCGLYCOMIMETICS INCSANDELL SCOTT D10% OwnerBuyX0.33216,04671,2954,706,7974.5 M to 4.7 M (+4.81 %)
May 11 2018GLYCGLYCOMIMETICS INCBARRIS PETER J10% OwnerOption ExerciseX0.33298,40698,4740
May 11 2018GLYCGLYCOMIMETICS INCBARRIS PETER J10% OwnerOption ExerciseX0.33216,04671,2950
May 11 2018GLYCGLYCOMIMETICS INCBARRIS PETER J10% OwnerSellS17.815,53398,5434,995,6645 M to 5 M (-0.11 %)
May 11 2018GLYCGLYCOMIMETICS INCBARRIS PETER J10% OwnerBuyX0.33298,40698,4745,001,1974.7 M to 5 M (+6.35 %)
May 11 2018GLYCGLYCOMIMETICS INCBARRIS PETER J10% OwnerSellS17.814,00671,3474,702,7914.7 M to 4.7 M (-0.09 %)
May 11 2018GLYCGLYCOMIMETICS INCBARRIS PETER J10% OwnerBuyX0.33216,04671,2954,706,7974.5 M to 4.7 M (+4.81 %)
May 11 2018GLYCGLYCOMIMETICS INCBARRETT M JAMESDirectorOption ExerciseX0.33298,40698,4740
May 11 2018GLYCGLYCOMIMETICS INCBARRETT M JAMESDirectorOption ExerciseX0.33216,04671,2950
May 11 2018GLYCGLYCOMIMETICS INCBARRETT M JAMESDirectorSellS17.815,53398,5434,995,6645 M to 5 M (-0.11 %)
May 11 2018GLYCGLYCOMIMETICS INCBARRETT M JAMESDirectorBuyX0.33298,40698,4745,001,1974.7 M to 5 M (+6.35 %)
May 11 2018GLYCGLYCOMIMETICS INCBARRETT M JAMESDirectorSellS17.814,00671,3474,702,7914.7 M to 4.7 M (-0.09 %)
May 11 2018GLYCGLYCOMIMETICS INCBARRETT M JAMESDirectorBuyX0.33216,04671,2954,706,7974.5 M to 4.7 M (+4.81 %)
May 11 2018GLYCGLYCOMIMETICS INCNEW ENTERPRISE ASSOCIATES 10 L ...10% OwnerOption ExerciseX0.33298,40698,4740
May 11 2018GLYCGLYCOMIMETICS INCNEW ENTERPRISE ASSOCIATES 10 L ...10% OwnerOption ExerciseX0.33216,04671,2950
May 11 2018GLYCGLYCOMIMETICS INCNEW ENTERPRISE ASSOCIATES 10 L ...10% OwnerSellS17.815,53398,5434,995,6645 M to 5 M (-0.11 %)
May 11 2018GLYCGLYCOMIMETICS INCNEW ENTERPRISE ASSOCIATES 10 L ...10% OwnerBuyX0.33298,40698,4745,001,1974.7 M to 5 M (+6.35 %)
May 11 2018GLYCGLYCOMIMETICS INCNEW ENTERPRISE ASSOCIATES 10 L ...10% OwnerSellS17.814,00671,3474,702,7914.7 M to 4.7 M (-0.09 %)
May 11 2018GLYCGLYCOMIMETICS INCNEW ENTERPRISE ASSOCIATES 10 L ...10% OwnerBuyX0.33216,04671,2954,706,7974.5 M to 4.7 M (+4.81 %)
Jan 12 2018GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOOption ExerciseA20.03175,0003,505,250175,000
Jan 12 2018GLYCGLYCOMIMETICS INCThackray Helen M.SVP Clinical Develo ...Option ExerciseA20.0375,0001,502,25075,000
Jan 12 2018GLYCGLYCOMIMETICS INCMagnani John L.SVP of Research, CS ...Option ExerciseA20.0375,0001,502,25075,000
Jan 12 2018GLYCGLYCOMIMETICS INCHahn Brian M.CFOOption ExerciseA20.0365,0001,301,95065,000
Dec 12 2017GLYCGLYCOMIMETICS INCThackray Helen M.SVP Clinical Develo ...SellS15.012,00030,020148,615150.6 K to 148.6 K (-1.33 %)
Sep 18 2017GLYCGLYCOMIMETICS INCThackray Helen M.SVP Clinical Develo ...SellS13.002,00026,000150,615152.6 K to 150.6 K (-1.31 %)
Jun 16 2017GLYCGLYCOMIMETICS INCJUNIUS DANIEL MDirectorGrantA11.273,00033,8108,0005 K to 8 K (+60.00 %)
Jun 12 2017GLYCGLYCOMIMETICS INCAndrews Patricia SDirectorOption ExerciseA11.6322,000255,86022,000
May 30 2017GLYCGLYCOMIMETICS INCBARRETT M JAMESDirectorOption ExerciseA13.8911,000152,79011,000
May 30 2017GLYCGLYCOMIMETICS INCPEARSON TIMOTHY RDirectorOption ExerciseA13.8911,000152,79011,000
May 30 2017GLYCGLYCOMIMETICS INCKoenig ScottDirectorOption ExerciseA13.8911,000152,79011,000
May 30 2017GLYCGLYCOMIMETICS INCJUNIUS DANIEL MDirectorOption ExerciseA13.8911,000152,79011,000
May 30 2017GLYCGLYCOMIMETICS INCGoldberg Mark AlanDirectorOption ExerciseA13.8911,000152,79011,000
May 30 2017GLYCGLYCOMIMETICS INCThackray Helen M.SVP Clinical Develo ...SellS15.572,00031,140152,615154.6 K to 152.6 K (-1.29 %)
May 22 2017GLYCGLYCOMIMETICS INCThackray Helen M.SVP Clinical Develo ...SellS12.142,00024,280154,615156.6 K to 154.6 K (-1.28 %)
May 11 2017GLYCGLYCOMIMETICS INCMagnani John L.SVP of Research, CS ...Option ExerciseM1.128,9289,999213,967
May 11 2017GLYCGLYCOMIMETICS INCMagnani John L.SVP of Research, CS ...BuyM1.128,9289,99999,30290.4 K to 99.3 K (+9.88 %)
Mar 13 2017GLYCGLYCOMIMETICS INCKoenig ScottDirectorOption ExerciseA6.5922,000144,98022,000
Jan 05 2017GLYCGLYCOMIMETICS INCMagnani John L.SVP of Research, CS ...Option ExerciseA6.3375,000474,75075,000
Jan 05 2017GLYCGLYCOMIMETICS INCThackray Helen M.SVP Clinical Develo ...Option ExerciseA6.3375,000474,75075,000
Jan 05 2017GLYCGLYCOMIMETICS INCHahn Brian M.CFOOption ExerciseA6.3365,000411,45065,000
Jan 05 2017GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOOption ExerciseA6.33175,0001,107,750175,000
Dec 21 2016GLYCGLYCOMIMETICS INCJUNIUS DANIEL MDirectorBuyP6.015,00030,0505,0000 to 5 K
Oct 04 2016GLYCGLYCOMIMETICS INCThackray Helen M.VP Clinical Develop ...SellS7.01100701156,615156.7 K to 156.6 K (-0.06 %)
Oct 04 2016GLYCGLYCOMIMETICS INCThackray Helen M.VP Clinical Develop ...SellS7.003,90027,300156,715160.6 K to 156.7 K (-2.43 %)
Jul 21 2016GLYCGLYCOMIMETICS INCThackray Helen M.VP Clinical Develop ...SellS8.002,00016,000160,615162.6 K to 160.6 K (-1.23 %)
Jul 06 2016GLYCGLYCOMIMETICS INCThackray Helen M.VP Clinical Develop ...SellS6.686,79645,397162,615169.4 K to 162.6 K (-4.01 %)
Jul 06 2016GLYCGLYCOMIMETICS INCThackray Helen M.VP Clinical Develop ...SellS7.0110,13671,053169,411179.5 K to 169.4 K (-5.65 %)
Jul 06 2016GLYCGLYCOMIMETICS INCThackray Helen M.VP Clinical Develop ...SellS7.405,06837,503179,547184.6 K to 179.5 K (-2.75 %)
Jul 01 2016GLYCGLYCOMIMETICS INCBaldwin John J.DirectorOption ExerciseM1.126056780
Jul 01 2016GLYCGLYCOMIMETICS INCBaldwin John J.DirectorOption ExerciseM1.126056780
Jul 01 2016GLYCGLYCOMIMETICS INCBaldwin John J.DirectorBuyM1.126056781,210605 to 1.2 K (+100.00 %)
Jul 01 2016GLYCGLYCOMIMETICS INCBaldwin John J.DirectorBuyM1.126056781,210605 to 1.2 K (+100.00 %)
May 19 2016GLYCGLYCOMIMETICS INCJUNIUS DANIEL MDirectorOption ExerciseA6.3511,00069,85011,000
May 19 2016GLYCGLYCOMIMETICS INCTOP FRANKLIN H JRDirectorOption ExerciseA6.3511,00069,85011,000
May 19 2016GLYCGLYCOMIMETICS INCPEARSON TIMOTHY RDirectorOption ExerciseA6.3511,00069,85011,000
May 19 2016GLYCGLYCOMIMETICS INCBARRETT M JAMESDirectorOption ExerciseA6.3511,00069,85011,000
May 19 2016GLYCGLYCOMIMETICS INCGoldberg Mark AlanDirectorOption ExerciseA6.3511,00069,85011,000
May 19 2016GLYCGLYCOMIMETICS INCBaldwin John J.DirectorOption ExerciseA6.3511,00069,85011,000
Mar 21 2016GLYCGLYCOMIMETICS INCJUNIUS DANIEL MDirectorOption ExerciseA5.9922,000131,78022,000
Mar 07 2016GLYCGLYCOMIMETICS INCGoldberg Mark AlanDirectorBuyP4.7710,39749,63011,4971.1 K to 11.5 K (+945.18 %)
Feb 12 2016GLYCGLYCOMIMETICS INCTOP FRANKLIN H JRDirectorOption ExerciseM1.1211,08412,4140
Feb 12 2016GLYCGLYCOMIMETICS INCTOP FRANKLIN H JRDirectorOption ExerciseM1.126056780
Feb 12 2016GLYCGLYCOMIMETICS INCTOP FRANKLIN H JRDirectorBuyM1.1211,68913,09212,294605 to 12.3 K (+1,932.07 %)
Jan 11 2016GLYCGLYCOMIMETICS INCHahn Brian M.CFOOption ExerciseA5.2265,000339,30065,000
Jan 11 2016GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOOption ExerciseA5.22141,000736,020141,000
Jan 11 2016GLYCGLYCOMIMETICS INCMagnani John L.VP of Research, CSOOption ExerciseA5.2271,000370,62071,000
Jan 11 2016GLYCGLYCOMIMETICS INCThackray Helen M.VP Clinical Develop ...Option ExerciseA5.2271,000370,62071,000
Nov 18 2015GLYCGLYCOMIMETICS INCSANDELL SCOTT D10% OwnerOption ExerciseX0.339,4453,1170
Nov 18 2015GLYCGLYCOMIMETICS INCSANDELL SCOTT D10% OwnerSellS6.914523,1234,490,7514.5 M to 4.5 M (-0.01 %)
Nov 18 2015GLYCGLYCOMIMETICS INCSANDELL SCOTT D10% OwnerBuyX0.339,4453,1174,491,2034.5 M to 4.5 M (+0.21 %)
Nov 18 2015GLYCGLYCOMIMETICS INCBARRIS PETER J10% OwnerOption ExerciseX0.339,4453,1170
Nov 18 2015GLYCGLYCOMIMETICS INCBARRIS PETER J10% OwnerSellS6.914523,1234,490,7514.5 M to 4.5 M (-0.01 %)
Nov 18 2015GLYCGLYCOMIMETICS INCBARRIS PETER J10% OwnerBuyX0.339,4453,1174,491,2034.5 M to 4.5 M (+0.21 %)
Nov 18 2015GLYCGLYCOMIMETICS INCBARRETT M JAMESDirectorOption ExerciseX0.339,4453,1170
Nov 18 2015GLYCGLYCOMIMETICS INCBARRETT M JAMESDirectorSellS6.914523,1234,490,7514.5 M to 4.5 M (-0.01 %)

Page:   1 2 next >

Contact us | Follow us on Twitter